Education
About Us
Working with TipRanks
Follow Us
Diagonal Bio AB (SE:DIABIO)
:DIABIO
DIABIO Stock Chart & Stats
Day’s Range― - ―
52-Week Range<kr0.01 - kr0.03
Previous CloseN/A
Volume1.36M
Average Volume (3M)11.20M
Market Cap
kr11.48M
Enterprise Valuekr6.92M
Total Cash (Recent Filing)kr1.73M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta-0.27
Next Earnings
Aug 22, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,639,322,000
10 Day Avg. Volume13,799,246
30 Day Avg. Volume11,202,001
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
DIABIO FAQ
What was Diagonal Bio AB’s price range in the past 12 months?
Diagonal Bio AB lowest stock price was <kr0.01 and its highest was kr0.03 in the past 12 months.
What is Diagonal Bio AB’s market cap?
Diagonal Bio AB’s market cap is kr11.48M.
When is Diagonal Bio AB’s upcoming earnings report date?
Diagonal Bio AB’s upcoming earnings report date is Aug 22, 2025 which is today.
How were Diagonal Bio AB’s earnings last quarter?
Currently, no data Available
Is Diagonal Bio AB overvalued?
According to Wall Street analysts Diagonal Bio AB’s price is currently Overvalued.
Does Diagonal Bio AB pay dividends?
Diagonal Bio AB does not currently pay dividends.
What is Diagonal Bio AB’s EPS estimate?
Diagonal Bio AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Diagonal Bio AB have?
Diagonal Bio AB has 1,639,322,000 shares outstanding.
What happened to Diagonal Bio AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Diagonal Bio AB?
Currently, no hedge funds are holding shares in SE:DIABIO
Company Description
Diagonal Bio AB
Diagonal Bio AB is developing a diagnostic platform for ultra-rapid, parallel, accurate and cost-efficient detection of any kind of pathogen - Panviral.
Technical Analysis
Stayble Therapeutics AB
―
LIDDS AB
―
CombiGene AB
―
Fluicell AB
―
QuiaPEG Pharmaceuticals Holding AB
―